The sale of Opella, a paracetamol manufacturer, to a US investment fund for €15 billion has been approved by the French government.
The deal includes guarantees for employment, production, and investment, addressing concerns about potential job losses and the impact on pharmaceutical supply chains in Europe.
Blocking the deal would not result in better guarantees, as foreign investment is seen as crucial for enhancing France's medicine manufacturing capabilities. The government will conduct an investment screening process for the takeover, with further details to be provided by Industry Minister Marc Ferracci and Armand on Monday.